
Vol. 20, No. 2, 2001
Free Abstract
Article (References)
Article (PDF 213 KB)
Invited Review
Assessing the Clinical Importance of Statistically Significant Improvement in Anti-Dementia Drug Trials
Kenneth Rockwooda,b, Chris MacKnighta
aDivision of Geriatric Medicine, Department of Medicine, and bDepartment of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada
Address of Corresponding Author
Neuroepidemiology 2001;20:51-56 (DOI: 10.1159/000054761)
Key Words
- Alzheimer's disease
- Controlled trials
- Clinical importance
Abstract
A strategy for assessing the clinical importance of statistically significant treatment benefits in recent dementia drug trials is proposed. Traditional criteria for the assessment of valid inferences are helpful: the more likely the treatment effects are valid, the greater the chance that they will be clinically important. The role of the Clinician's Interview-Based Impression of Change is also of some importance. Progress in this area faces the special challenge that the 'new' disease entity of partial treatment of Alzheimer's disease has not been well described. Large, systematic clinical studies of treated patients remain necessary to define reliable guides to successful treatment. Copyright © 2001 S. Karger AG, Basel
Author Contacts
Kenneth Rockwood Centre for Health Care of the Elderly 5955 Jubilee Road, Room 1421 Halifax, NS B3H 2E1 (Canada) Tel. +1 902 473 8687, Fax +1 902 473 1050, E-Mail rockwood@is.dal.ca
Article Information
Number of Print Pages : 6
Number of Figures : 0, Number of Tables : 0, Number of References : 41 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their research paper editing service. |
|
|